메뉴 건너뛰기




Volumn 47, Issue 3, 2006, Pages 455-461

Adherence to guidelines for ESRD anemia management

Author keywords

Anemia management; Clinical guidelines; End stage renal disease (ESRD); Erythropoietin; Veterans

Indexed keywords

ERYTHROPOIETIN;

EID: 32844462617     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.11.012     Document Type: Article
Times cited : (23)

References (19)
  • 1
    • 0032572915 scopus 로고    scopus 로고
    • Erythropoietin for end-stage renal disease
    • J.W. Adamson, J.W. Eschbach Erythropoietin for end-stage renal disease N Engl J Med 339 1998 625 627
    • (1998) N Engl J Med , vol.339 , pp. 625-627
    • Adamson, J.W.1    Eschbach, J.W.2
  • 3
    • 0037082566 scopus 로고    scopus 로고
    • Potential cost savings of epoetin administration in end-stage renal disease
    • D.M. Hynes, K.T. Stroupe, J.W. Greer Potential cost savings of epoetin administration in end-stage renal disease Am J Med 112 2002 169 175
    • (2002) Am J Med , vol.112 , pp. 169-175
    • Hynes, D.M.1    Stroupe, K.T.2    Greer, J.W.3
  • 4
    • 0025727829 scopus 로고
    • Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant epoetin twice a week: A long-term study
    • I.K. Cheng, C. Cy, M.K. Chan, L. Yu, G.X. Fang, D. Wei Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant epoetin twice a week A long-term study Clin Nephrol 35 1991 207 212
    • (1991) Clin Nephrol , vol.35 , pp. 207-212
    • Cheng, I.K.1    Cy, C.2    Chan, M.K.3    Yu, L.4    Fang, G.X.5    Wei, D.6
  • 5
    • 0032572918 scopus 로고    scopus 로고
    • Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis
    • Department of VA Cooperative Study Group on Erythropoietin in Hemodialysis Patients C.L.
    • J.S. Kaufman, D.J. Reda, C.L. Fye Department of VA Cooperative Study Group on Erythropoietin in Hemodialysis Patients Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis N Engl J Med 339 1998 578 583
    • (1998) N Engl J Med , vol.339 , pp. 578-583
    • Kaufman, J.S.1    Reda, D.J.2    Fye3
  • 6
    • 0037106169 scopus 로고    scopus 로고
    • Switching from i.v. to s.c. epoetin in hemodialysis patients
    • M.D. Knauss, T. Walton, E.J. Macon Switching from i.v. to s.c. epoetin in hemodialysis patients Am J Health Syst Pharm 59 2002 1783 1784
    • (2002) Am J Health Syst Pharm , vol.59 , pp. 1783-1784
    • Knauss, M.D.1    Walton, T.2    MacOn, E.J.3
  • 7
    • 0038806683 scopus 로고    scopus 로고
    • The cost-effectiveness of maintaining higher hemoglobin targets with epoetin in hemodialysis patients
    • M. Tonelli, W.C. Winkelmayer, K.K. Jindal, W.F. Owen, B.J. Manns The cost-effectiveness of maintaining higher hemoglobin targets with epoetin in hemodialysis patients Kidney Int 64 2003 295 304
    • (2003) Kidney Int , vol.64 , pp. 295-304
    • Tonelli, M.1    Winkelmayer, W.C.2    Jindal, K.K.3    Owen, W.F.4    Manns, B.J.5
  • 8
    • 0035228407 scopus 로고    scopus 로고
    • K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
    • National Kidney Foundation
    • National Kidney Foundation K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease Update 2000 Am J Kidney Dis 37 suppl 1 2001 S182 S238
    • (2001) Am J Kidney Dis , vol.37 , Issue.1 SUPPL.
  • 9
    • 0030001078 scopus 로고    scopus 로고
    • Comparison of dose requirement, serum epoetin and blood pressure following intravenous and subcutaneous epoetin treatment of dialysis patients
    • J.D. Jensen, J.K. Madsen, L.W. Jensen Comparison of dose requirement, serum epoetin and blood pressure following intravenous and subcutaneous epoetin treatment of dialysis patients Eur J Clin Pharmacol 50 1996 171 177
    • (1996) Eur J Clin Pharmacol , vol.50 , pp. 171-177
    • Jensen, J.D.1    Madsen, J.K.2    Jensen, L.W.3
  • 11
    • 0036724397 scopus 로고    scopus 로고
    • Preaching and practice: Evidence-based medicine and the accountability of nephrologists within the health care system. the implications of the findings of the cost-saving potential of subcutaneous versus intravenous epoetin therapy
    • A. Levin Preaching and practice: Evidence-based medicine and the accountability of nephrologists within the health care system. The implications of the findings of the cost-saving potential of subcutaneous versus intravenous epoetin therapy Am J Kidney Dis 40 2002 662 663
    • (2002) Am J Kidney Dis , vol.40 , pp. 662-663
    • Levin, A.1
  • 12
    • 3042536665 scopus 로고    scopus 로고
    • Erythropoietin and renal failure
    • I.C. Macdougall Erythropoietin and renal failure Curr Hematol Rep 2 2003 459 464
    • (2003) Curr Hematol Rep , vol.2 , pp. 459-464
    • MacDougall, I.C.1
  • 13
    • 0042420751 scopus 로고    scopus 로고
    • Pure red-cell aplasia: An emerging epidemic in dialysis patients?
    • S. Anand, A.R. Nissenson Pure red-cell aplasia An emerging epidemic in dialysis patients? Perit Dial Int 23 2003 317 319
    • (2003) Perit Dial Int , vol.23 , pp. 317-319
    • Anand, S.1    Nissenson, A.R.2
  • 14
    • 1642435683 scopus 로고    scopus 로고
    • Pure red cell aplasia secondary to treatment with epoetin
    • F. Locatelli, L. Del Vecchio Pure red cell aplasia secondary to treatment with epoetin J Nephrol 16 2003 461 466
    • (2003) J Nephrol , vol.16 , pp. 461-466
    • Locatelli, F.1    Del Vecchio, L.2
  • 16
    • 0031682322 scopus 로고    scopus 로고
    • Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of Epogen in hemodialysis patients
    • W.L. St Peter, M.J. Lewis, M.G. Macres Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of Epogen in hemodialysis patients Am J Kidney Dis 32 1998 470 474
    • (1998) Am J Kidney Dis , vol.32 , pp. 470-474
    • St Peter, W.L.1    Lewis, M.J.2    MacRes, M.G.3
  • 17
    • 0036283349 scopus 로고    scopus 로고
    • Once-weekly compared with three-times-weekly subcutaneous epoetin beta: Results from a randomized, multicenter, therapeutic-equivalence study
    • F. Locatelli, C.A. Baldamus, G. Villa, A. Ganea, A.L. Martin de Francisco Once-weekly compared with three-times-weekly subcutaneous epoetin beta Results from a randomized, multicenter, therapeutic-equivalence study Am J Kidney Dis 40 2002 119 125
    • (2002) Am J Kidney Dis , vol.40 , pp. 119-125
    • Locatelli, F.1    Baldamus, C.A.2    Villa, G.3    Ganea, A.4    Martin De Francisco, A.L.5
  • 19
    • 0036724273 scopus 로고    scopus 로고
    • Meta-analysis of subcutaneous versus intravenous epoetinetin in maintenance treatment of anemia in hemodialysis patients
    • A. Besarab, C.M. Reyes, J. Hornberger Meta-analysis of subcutaneous versus intravenous epoetinetin in maintenance treatment of anemia in hemodialysis patients Am J Kidney Dis 40 2002 439 446
    • (2002) Am J Kidney Dis , vol.40 , pp. 439-446
    • Besarab, A.1    Reyes, C.M.2    Hornberger, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.